Guangdong Blue Treasure Pharmaceuticals Co.,Ltd.

Guangdong Lanbao Pharmaceutical Co., Ltd. is a modern pharmaceutical enterprise jointly established by Canada Abetek Fermentation Co., Ltd., Xinbeijiang Pharmaceutical Co., Ltd. of Livzon Group, Sichuan Antibiotics Industrial Research Institute of China National Pharmaceutical Group Corporation, Livzon Pharmaceutical Group Co., Ltd., and Swiss Biotech Far East Co., Ltd., with a registered capital of US$7.53 million and a total investment of US$8.53 million. Lanbao Pharmaceutical was established in 1994. The company covers an area of ​​18,916 square meters and a construction area of ​​10,099 square meters. The plant facilities are designed and built in accordance with international CGMP standards, and the main production equipment and testing instruments are imported from the United States, Switzerland and other countries. The company is mainly committed to the development and production of new blood lipid regulating drugs and new immunosuppressants, and has successfully introduced products such as lovastatin, mevastatin/compatin, pravastatin sodium and mycophenolic acid from abroad. The company has passed the US FDA/CGMP certification, the European COS/CEP certification and the Australian TGA/CGMP certification. The clean and elegant factory area, advanced production equipment, and a high-quality workforce produce high-quality products under a complete management system, and the product quality meets the international advanced pharmaceutical standards.